A post hoc analysis of the phase III True North study showed that the benefits of ozanimod on clinical remission and response in patients with moderate-to-severe ulcerative colitis (UC) as seen in the global analysis were consistent in the analysis of the North American cohort.
The gut bacteria are crucial to health and the variable that links inflammatory bowel disease (IBD) to diet. What people eat shapes the composition of bugs that live in the gut, and an imbalance in this composition can promote a range of medical conditions, including IBD. It follows that diet may be involved in the development of IBD, and that diet may be a potential therapy, according to an expert.
Using biologic/small molecules*, systemic steroids, or other agents** to treat patients with inflammatory bowel disease (IBD) does not increase the rate of SARS-CoV-2 infection at 3 and 6 months post-immunization, according to a study presented at AIBD 2021.
In patients with inflammatory bowel disease (IBD), the likelihood of early treatment with vedolizumab is low, a finding that diverts from guideline recommendations, according to a real-world study presented at AIBD 2021.
A novel health tracker that is strapped around the wrist can detect changes in the physiology of individuals with inflammatory bowel disease (IBD) in real time, as shown in a study presented at the Advances in Inflammatory Bowel Diseases conference.
While there are no differences in COVID-19-related outcomes in patients with inflammatory bowel disease (IBD) between those in remission vs those who are not, being on medications such as corticosteroids and aminosalicylates may put them at higher risk of hospitalization, suggest studies presented at AIBD 2021.
Treatment with the anti-interleukin (IL)-12/-23 monoclonal antibody ustekinumab yields a high rate of clinical remission in patients with moderate-to-severe Crohn’s disease (CD) in the real-world setting, according to a study presented at AIBD 2021.
Frequent consumption of processed meat was found to be associated with an increased risk of mortality in individuals with inflammatory bowel disease (IBD), according to data presented at AIBD 2021. Conversely, this association was not seen with fish and unprocessed meat consumption.